It has been shown to stabilize c-Myc via S62 phosphorylation, promote STAT3 and ERK signaling, and support tumor growth in multiple myeloma and colitis-associated colorectal cancer, as well as contribute to cisplatin resistance through redox adaptation [52]. This evidence concerns the gene STAT3 and plasma cell myeloma.